SCHEMBL3160648

SCHEMBL3160648

CCO/C=C1\C(=O)Nc2cc(C(N)=O)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.44
PIM1 P11309 1/20 0.43
TGM2 P21980 3/20 0.42
ALDH1A1 P00352 3/20 0.39
APAF1 O14727 1/20 0.39
MAPK1 P28482 1/20 0.39
KDR P35968 2/20 0.38
CHEK1 O14757 1/20 0.38
PARP10 Q53GL7 1/20 0.38
PDGFRA P16234 1/20 0.37
MMP2 P08253 1/20 0.37
MMP13 P45452 1/20 0.37
FLT4 P35916 1/20 0.37
FLT3 P36888 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3160654 1.00 PDPK1 (0.44) PDPK1PIM1TGM2ALDH1A1APAF1
SCHEMBL3157679 0.79 PDPK1 (0.42) PDPK1PIM1TGM2MAPK1KDR
SCHEMBL11882118 0.76 SMN1; SMN2 (0.57) TGM2ALDH1A1MAPK1KDRFLT3
SCHEMBL3156405 0.75 PDPK1 (0.44) PDPK1PIM1TGM2KDRCHEK1
SCHEMBL30785016 0.74 PIM1 (0.52) PDPK1PIM1TGM2KDRCHEK1
SCHEMBL7238205 0.74 RET (0.55) PDPK1TGM2ALDH1A1APAF1FLT3
SCHEMBL7238212 0.74 RET (0.55) PDPK1TGM2ALDH1A1APAF1FLT3
SCHEMBL3160871 0.73 KMT2A (0.41) PDPK1PIM1TGM2ALDH1A1KDR
SCHEMBL3148743 0.73 PIM1 (0.46) PDPK1PIM1TGM2KDRPDGFRA
SCHEMBL2572615 0.72 FLT3 (0.42) PDPK1PIM1TGM2KDRFLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224170-B9 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA (DE) 2017-11-22 EP disclosed
EP-2157081-A1 Indolinones substituted in six locations, their manufacture and their application as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2010-02-24 EP disclosed
EP-1224170-B1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA (DE) 2009-08-12 EP disclosed
US-6762180-B1 Substituted indolines which inhibit receptor tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-07-13 US disclosed
EP-1224170-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT Boehringer Ingelheim Pharma KG (DE) 2002-07-24 EP disclosed
WO-2001027081-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-04-19 WO disclosed